Biocause Pharma's Insurance Unit Logs 31 Billion Yuan Insurance Premium Income in January-October Period

MT NewswiresNov 12 11:59

Express News | hubei biocause pharmaceutical: china best life insurance's original insurance premium income in January-October 2024 is approximately 31.386 billion yuan

BreakingsNov 11 17:37

Tianmao Group: Report for the third quarter of 2024

SZSIOct 31 00:00 · Announcements

A-share insurance sector rises, hubei biocause pharmaceutical surges more than 7%.

On October 23rd, Biocause Pharmaceutical rose by over 7%, Kaisa Jiayun Technology Inc., Qitian Technology Group, Shenzhen Kingdom Sci-Tech, Jiangxi Tianli Technology, Inc., Ping An Insurance, Xin Hua Insurance and other companies followed the upward trend.

Gelonghui FinanceOct 23 10:20

Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024

SZSIOct 15 00:00 · Announcements

hubei biocause pharmaceutical (000627.SZ) issued a profit warning, expecting a net loss of 0.315 billion yuan to 0.345 billion yuan in the first three quarters.

hubei biocause pharmaceutical (000627.SZ) released the performance forecast for the first three quarters of 2024, expecting the attributable net profit for the first three quarters to be above...

Zhitong FinanceOct 14 19:40